Zuppinger Christian
Cardiology, Department of Biomedical Research, Bern University Hospital, Bern, Switzerland.
Front Cardiovasc Med. 2019 Jun 26;6:87. doi: 10.3389/fcvm.2019.00087. eCollection 2019.
Three-dimensional (3D) cell culture is often mentioned in the context of regenerative medicine, for example, for the replacement of ischemic myocardium with tissue-engineered muscle constructs. Additionally, 3D cell culture is used, although less commonly, in basic research, toxicology, and drug development. These applications have recently benefited from innovations in stem cell technologies allowing the mass-production of hiPSC-derived cardiomyocytes or other cardiovascular cells, and from new culturing methods including organ-on-chip and bioprinting technologies. On the analysis side, improved sensors, computer-assisted image analysis, and data collection techniques have lowered the bar for switching to 3D cell culture models. Nevertheless, 3D cell culture is not as widespread or standardized as traditional cell culture methods using monolayers of cells on flat surfaces. The many possibilities of 3D cell culture, but also its limitations, drawbacks and methodological pitfalls, are less well-known. This article reviews currently used cardiovascular 3D cell culture production methods and analysis techniques for the investigation of cardiotoxicity, in drug development and for disease modeling.
三维(3D)细胞培养在再生医学领域常被提及,例如,用于用组织工程肌肉构建体替代缺血心肌。此外,3D细胞培养在基础研究、毒理学和药物开发中也有应用,尽管不太常见。这些应用最近受益于干细胞技术的创新,使得能够大规模生产人诱导多能干细胞衍生的心肌细胞或其他心血管细胞,以及包括芯片器官和生物打印技术在内的新培养方法。在分析方面,改进的传感器、计算机辅助图像分析和数据收集技术降低了转向3D细胞培养模型的门槛。然而,3D细胞培养不像在平坦表面上使用单层细胞的传统细胞培养方法那样广泛或标准化。3D细胞培养的众多可能性,以及它的局限性、缺点和方法陷阱,鲜为人知。本文综述了目前用于药物开发中研究心脏毒性和疾病建模的心血管3D细胞培养生产方法和分析技术。